Literature DB >> 21161696

Immunologic aspects of monoclonal B-cell lymphocytosis.

Mark C Lanasa1, J Brice Weinberg.   

Abstract

Monoclonal B-cell lymphocytosis (MBL) is a preclinical hematologic condition wherein small numbers of clonal B cells can be detected in the blood of otherwise healthy individuals. Most MBL have a surface immunophenotype nearly identical to that of chronic lymphocytic leukemia (CLL), though other phenotypes can also be identified. MBL has been shown to be a precursor state for CLL, but most MBL clones are quite small and apparently have minimal potential to progress of CLL or other B-cell lymphoproliferative disorder (B-LPD). The investigation of MBL as a precursor state for CLL will likely lead to important insights into mechanisms of disease pathogenesis. The review will cover clinical and translational aspects of MBL, with a particular emphasis on the prevalence of MBL; the relationship between MBL, CLL, and other B-LPDs; and the capacity of MBL to modulate the normal B- and T-cell compartments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21161696      PMCID: PMC4102133          DOI: 10.1007/s12026-010-8188-4

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  54 in total

1.  Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset.

Authors:  M R Rezvany; M Jeddi-Tehrani; A Osterborg; E Kimby; H Wigzell; H Mellstedt
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

Review 2.  Chronic lymphocytic leukemia.

Authors:  Nicholas Chiorazzi; Kanti R Rai; Manlio Ferrarini
Journal:  N Engl J Med       Date:  2005-02-24       Impact factor: 91.245

3.  Statistical analysis of antigen receptor spectratype data.

Authors:  Thomas B Kepler; Min He; John K Tomfohr; Blythe H Devlin; Marcella Sarzotti; M Louise Markert
Journal:  Bioinformatics       Date:  2005-06-14       Impact factor: 6.937

4.  Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation.

Authors:  M Fischer; U Klein; R Küppers
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

5.  Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.

Authors:  Güllü Görgün; Tobias A W Holderried; David Zahrieh; Donna Neuberg; John G Gribben
Journal:  J Clin Invest       Date:  2005-06-16       Impact factor: 14.808

Review 6.  Diagnostic criteria for monoclonal B-cell lymphocytosis.

Authors:  Gerald E Marti; Andy C Rawstron; Paolo Ghia; Peter Hillmen; Richard S Houlston; Neil Kay; Thérèse A Schleinitz; Neil Caporaso
Journal:  Br J Haematol       Date:  2005-08       Impact factor: 6.998

7.  Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia.

Authors:  M Motta; L Rassenti; B J Shelvin; S Lerner; T J Kipps; M J Keating; W G Wierda
Journal:  Leukemia       Date:  2005-10       Impact factor: 11.528

8.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

Authors:  T J Hamblin; Z Davis; A Gardiner; D G Oscier; F K Stevenson
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

9.  Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine.

Authors:  Marc Beyer; Matthias Kochanek; Kamruz Darabi; Alexey Popov; Markus Jensen; Elmar Endl; Percy A Knolle; Roman K Thomas; Michael von Bergwelt-Baildon; Svenja Debey; Michael Hallek; Joachim L Schultze
Journal:  Blood       Date:  2005-05-24       Impact factor: 22.113

10.  Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

Authors:  F Fais; F Ghiotto; S Hashimoto; B Sellars; A Valetto; S L Allen; P Schulman; V P Vinciguerra; K Rai; L Z Rassenti; T J Kipps; G Dighiero; H W Schroeder; M Ferrarini; N Chiorazzi
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

View more
  6 in total

1.  Monoclonal B-cell lymphocytosis (MBL, CD4+/CD8 weak T-cell large granular lymphocytic leukemia (T-LGL leukemia) and monoclonal gammopathy of unknown significance (MGUS): molecular and flow cytometry characterization of three concomitant hematological disorders.

Authors:  Daniel Mazza Matos; Ana Cesarina Vitoriano de Oliveira; Maria de Nazaré Amaral Tomé; Carlos Alberto Scrideli
Journal:  Med Oncol       Date:  2012-06-12       Impact factor: 3.064

2.  Dicamba use and cancer incidence in the agricultural health study: an updated analysis.

Authors:  Catherine C Lerro; Jonathan N Hofmann; Gabriella Andreotti; Stella Koutros; Christine G Parks; Aaron Blair; Paul S Albert; Jay H Lubin; Dale P Sandler; Laura E Beane Freeman
Journal:  Int J Epidemiol       Date:  2020-08-01       Impact factor: 7.196

Review 3.  Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia.

Authors:  Valentina Griggio; Francesca Perutelli; Chiara Salvetti; Elia Boccellato; Mario Boccadoro; Candida Vitale; Marta Coscia
Journal:  Front Immunol       Date:  2020-11-18       Impact factor: 7.561

4.  Frequency of monoclonal B-cell lymphocytosis in relatives of patients with chronic lymphocytic leukemia.

Authors:  Rossana Villegas Gracia; Catalina Franco Alzate; Javier Rendón Henao; José Domingo Torres Hernández; Patricia Elena Jaramillo Arbelaez
Journal:  Colomb Med (Cali)       Date:  2016-06-30

5.  Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression.

Authors:  Ignacio Criado; Santiago Muñoz-Criado; Arancha Rodríguez-Caballero; Wendy G Nieto; Alfonso Romero; Paulino Fernández-Navarro; Miguel Alcoceba; Teresa Contreras; Marcos González; Alberto Orfao; Julia Almeida
Journal:  Haematologica       Date:  2017-04-06       Impact factor: 9.941

6.  Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report.

Authors:  Birgitte Tholin; Marit Teigen Hauge; Pål Aukrust; Lutz Fehrle; Tor Henrik Tvedt
Journal:  J Med Case Rep       Date:  2020-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.